Startup Valuation Methods: When to Use DCF, Comparables, or the VC Method
Ask three investors how to value your startup and you may get three different numbers. That is not a sign that valuation is arbitrary. It is a sign that method matters as much as math.
DCF, comparable company analysis, and the VC method are all legitimate valuation frameworks. Each one is built on different assumptions, requires different inputs, and produces a different kind of answer. Used in the right context, each is defensible. Used in the wrong one, each falls apart quickly under investor scrutiny.
The problem is that most founders treat valuation as a single-answer problem. They pick a method, or let an advisor pick one for them, and present the result as the number. Investors, meanwhile, are quietly running their own analysis from a different starting point. That gap is where fundraising conversations break down.
This article walks through how each method works, when it applies, and how to choose the right approach for your stage and context. The goal is not to produce a formula. It is to help founders understand the logic investors are actually using, so the conversation moves forward instead of stalling on a number no one agrees on.
-
Method choice shapes the number. DCF, comparables, and the VC method are all legitimate frameworks. Each is built on different assumptions and produces a different answer. Using the wrong method for your stage is one of the most common reasons fundraising conversations stall.
-
Comp selection is the valuation. Comparable company analysis is only as good as the peer set behind it. Matching on category label instead of stage, business model, and unit economics is where most comp-based valuations break down under scrutiny.
-
DCF is dangerous when visibility is low. In early-stage startups, terminal value can account for 80 to 90 percent of a DCF output. Small changes in discount rate or growth assumptions swing the result dramatically, which is why DCF carries the most risk when it is used earliest.
-
Investors triangulate. Founders should too. No single method produces a definitive answer. The goal is a defensible range built from multiple approaches, not a single number that collapses the moment an investor runs their own model.
Topics covered in this article +
- The three methods at a glance
- Method 1: Comparable company analysis
- How it works and when it applies
- The comp selection trap
- Method 2: Discounted cash flow (DCF)
- Why terminal value dominates early
- When DCF becomes meaningful
- Method 3: The VC method
- Return-driven, not fundamentals-driven
- How to interpret it as a founder
- How to choose: a stage-by-stage framework
- Why investors triangulate across methods
- Common mistakes that undermine any valuation
- Why founders work with Finro on startup valuation
- Key takeaways
- Answers to the most asked questions
Method 1: Comparable Company Analysis
Comparable company analysis, also called the comps method or market approach, estimates a startup's value by benchmarking it against similar companies. The logic is straightforward: if investors are pricing comparable businesses at a certain multiple of revenue or EBITDA, your company should trade in a similar range, adjusted for differences in growth, margin, and risk.
In practice, the method produces a valuation range by applying peer multiples to your own financials or operational metrics. For public companies, EV/Revenue and EV/EBITDA are the most common multiples. For private startups, the analysis draws on funding round data, acquisition transactions, and, where available, disclosed revenue figures from comparable peers.
When it applies
Comps is the most broadly applicable of the three methods. It can be used from seed stage onwards, which makes it the default starting point for most startup valuations.
That said, what "comps" means in practice changes significantly depending on where a company is in its development. For pre-revenue startups, revenue multiples are not yet available, so the analysis shifts to alternative inputs: ARR run rate, GMV, user growth, or sector-specific KPIs that investors in that niche actually use to price deals. The peer set also becomes harder to construct because fewer direct comparables exist at early stages, and the ones that do exist may not have disclosed enough financial detail to anchor a defensible range.
Post-revenue, the method gains considerably more traction. Revenue multiples become applicable, the peer set is easier to justify, and the resulting range is more likely to hold up in an investor conversation without requiring extensive qualification.
Defensibility over time
Of the three methods, comps has the clearest defensibility trajectory. The more revenue visibility you have, the more anchored the peer set becomes, and the harder it is for an investor to dismiss the range as speculative.
At the pre-revenue stage, a comps-based valuation is directional rather than definitive. It tells you where the market is pricing similar businesses, but the absence of your own financial metrics means the range carries wider uncertainty. At Series A and beyond, comps becomes the primary method most investors and acquirers will run independently. By that point, a well-constructed peer set with explicit rationale is not just useful, it is expected.
The practical implication for founders is that comps should be part of the valuation framework from early on, even if the inputs are imprecise, because it builds the habit of tracking the right benchmarks and anchoring to market reality rather than internal assumptions.
The comp selection trap
The most common failure in comparable company analysis is not in the math. It is in the peer set.
Matching on category label rather than business model, stage, and unit economics produces a range that looks rigorous but collapses under scrutiny. A payments company and a lending platform both operate in fintech, but their revenue models, margin structures, and investor expectations are fundamentally different. Putting them in the same comp set introduces noise that distorts the multiple range in ways that are hard to defend.
The same problem applies to stage mismatch. A pre-revenue startup benchmarked against Series C companies with proven retention and expanding margins will almost always look underpriced or overpriced depending on which multiples are selected. The peer set needs to match on growth profile and unit economics, not just sector classification.
What founders get wrong
The most common mistake is cherry-picking. Founders naturally gravitate toward the high end of the multiple range, anchoring to the best-performing comps while downplaying the ones that trade lower. Investors notice this immediately. A comp set that excludes obvious peers without explanation signals that the valuation was built to reach a conclusion rather than to reflect market reality.
The second mistake is treating public market multiples as directly applicable to private startups without adjustment. Public companies carry a liquidity premium that private companies do not. Applying public multiples without a private market discount, typically ranging from 10 to 30 percent depending on stage and sector, produces a valuation that overestimates where a deal will actually price.
The third mistake is using stale data. Valuation multiples move with market conditions. A comp set built on 2021 data in a 2025 fundraising conversation will produce a range that no informed investor will accept. The benchmarks need to reflect current market conditions, which is why regularly updated sector datasets matter.
For a deeper look at how to build a defensible comp set step by step, including how to select peers, which multiples to use, and how to adjust for private market context, see How to Calculate a Startup Valuation Using the Comparables Method.
This process is how Finro builds comp sets across AI, fintech, cybersecurity, SaaS, and other technology sectors. The goal is a range that holds up when an investor, acquirer, or board member challenges it.
Method 2: Discounted Cash Flow (DCF)
The discounted cash flow method estimates a company's value based on the cash it is expected to generate in the future, discounted back to what those future cash flows are worth in today's terms. The core logic is that a dollar received five years from now is worth less than a dollar received today, and the discount rate applied to future cash flows reflects both the time value of money and the risk that those cash flows do not materialise as projected.
In practice, a DCF model projects free cash flows over a defined forecast period, typically five to ten years, then adds a terminal value to capture everything beyond that horizon. The terminal value and the projected cash flows are then discounted back at a rate that reflects the company's cost of capital, usually calculated using the weighted average cost of capital (WACC) for later-stage companies or a venture-adjusted discount rate for earlier ones. The discount rate itself draws on the beta collected during the comp set research, which is one reason building the comp set and the DCF from the same data foundation matters.
When it applies
DCF is most reliable when a company has enough financial history and operational visibility to build projections that are grounded in something real. That typically means post-revenue, with enough data to understand unit economics, retention curves, margin trajectory, and how growth scales with investment.
That said, the trigger is not a round label. It is the quality and visibility of the underlying cash flow logic. In industries where cash flow patterns are well understood, such as fintech lending, payments infrastructure, or SaaS with strong cohort data and predictable churn, DCF can be introduced meaningfully at earlier stages than the post-revenue baseline would suggest. In those cases it adds triangulation value alongside comps, even if the projections carry wider uncertainty than they would at a later stage.
For pre-revenue companies with no unit economics to anchor the model, DCF produces a number that is almost entirely a function of assumptions. It is not unusable, but it requires extreme transparency about what is being assumed and why, and it should not be the primary method.
Defensibility over time
Of the three methods, DCF has the steepest defensibility curve. The improvement from early stage to later stage is dramatic because the inputs that drive the model, revenue visibility, margin trajectory, churn, CAC payback, and cost of capital, all become more grounded as the business matures.
At the pre-revenue stage, a DCF is essentially a structured assumption exercise. The output is a range, not a number, and its value is more in the discipline of thinking through cash flow logic than in the precision of the result. At Series B and beyond, with two or more years of revenue history and measurable unit economics, DCF becomes a primary valuation tool that investors and acquirers will run independently. By that point, a well-constructed DCF with explicit, challengeable assumptions is expected rather than optional.
The practical implication is that founders should begin building the inputs for a DCF, retention data, margin structure, growth drivers, well before they need the model itself. The model is only as good as the operational data behind it.
The terminal value trap
The most structurally dangerous feature of DCF in early-stage valuations is terminal value dominance. In a company with limited near-term cash flows, terminal value can account for 80 to 90 percent of the total output. That means the vast majority of the valuation rests on assumptions about what the business will look like a decade from now, discounted at a rate that is itself an assumption.
The problem compounds when discount rates and long-term growth rates are chosen to produce a target number rather than to reflect reality. A two-percentage-point change in the discount rate applied to a high-growth startup can move the valuation by 30 to 50 percent. A one-percentage-point change in the terminal growth rate can have a similar effect. Investors who run their own models will probe exactly these inputs, and a DCF that cannot withstand a sensitivity test on its own key assumptions will not survive a serious diligence conversation.
What founders get wrong
The first and most common mistake is applying DCF too early without acknowledging the uncertainty it carries. Presenting a precise DCF valuation for a pre-revenue company signals either that the assumptions are too aggressive to be realistic or that the founder does not understand how much of the output is driven by terminal value rather than near-term performance.
The second mistake is using a discount rate that is too low. Early-stage startups carry significantly more risk than public companies or later-stage private peers. A discount rate anchored to public market WACC without a venture risk premium substantially overstates present value and produces a number that will not hold up when an investor applies their own required return.
The third mistake is building a single-scenario DCF. A model that produces one number without sensitivity analysis around the key drivers, growth rate, churn, margin, discount rate, tells an investor that the founder has not stress-tested their own assumptions. A DCF should always include a base case, a downside, and an upside, with clear explanations of what needs to be true for each outcome.
For a practical walkthrough of how to build and structure a DCF for a startup, including how to set the discount rate and handle terminal value, see A Quick and Dirty Guide for a Discounted Cash Flow Valuation.
Method 3: The VC Method
The VC method estimates what a company is worth today by working backwards from an expected future exit value. The logic is straightforward: a VC fund has a target return multiple, typically 10x or more for early-stage investments. If the fund expects to exit in five to seven years at a projected valuation, it can back-solve to the maximum price it is willing to pay today to hit that return.
The mechanics are simple. Estimate the company's exit value at a future date, usually based on revenue or EBITDA projections and a market multiple. Divide that exit value by the target return multiple to arrive at the post-money valuation the investor needs today. Subtract the investment amount to get the implied pre-money valuation.
When it applies
The VC method applies in a narrow and specific context: pre-product or pre-traction companies being evaluated by angel investors or small pre-seed funds. It is rarely the primary method used by institutional VCs beyond the earliest stages, and it fades in relevance quickly once a company has enough traction to support a comp-based or DCF analysis.
It is worth being direct about what the VC method actually is in practice. It is an internal deal-sizing tool. Angels and small pre-seed funds use it to quickly assess whether a deal can generate the return they need given the price being asked. It tells them whether the math works for their fund, not what the business is fundamentally worth. Most of the time, founders never see this calculation. They see the offer.
Defensibility over time
The VC method does not improve with data. Unlike comps, which become more defensible as revenue and peer matching improve, or DCF, which strengthens as cash flow visibility increases, the VC method is structurally fixed. It is a return construct built on an assumed exit value and a target multiple. Adding more operational data does not make it more accurate because accuracy is not what it is designed to produce. It is designed to answer one question: does this deal work for the investor?
This is what makes it the weakest of the three methods from a valuation standpoint. It reflects the investor's return requirements, not the company's intrinsic value or market-based pricing. Two investors with different return targets and different exit assumptions will produce two completely different VC method valuations for the same company.
The core trap
The trap for founders is treating the VC method output as the valuation rather than as one investor's required entry price. A pre-seed fund that offers a $4M pre-money valuation is not saying your company is worth $4M. It is saying that $4M is the price at which the deal works for their fund given their return target and exit assumptions.
Understanding this distinction matters in negotiation. If a founder knows the investor's assumed exit multiple and timeline, they can engage with the assumptions directly rather than treating the offered valuation as a fixed number. Changing the exit assumption by one or two turns of revenue can move the implied pre-money valuation meaningfully without changing the investor's underlying return logic.
What founders get wrong
The most common mistake is anchoring to the VC method as a reference point for what the company is worth, then carrying that number into later conversations where it does not belong. A valuation derived from an angel's required return multiple has no meaningful relationship to what a Series A investor, a strategic acquirer, or a financial buyer will pay. Using it as a benchmark in those conversations signals a misunderstanding of how each audience prices deals.
The second mistake is not running the VC method themselves before entering a negotiation. Knowing how an angel or pre-seed fund is likely to size the deal, what exit multiple they are assuming, what return they need, puts founders in a much stronger position to respond to an offer with something more than a counter-number.
Change the exit revenue assumption from $5M to $8M and the implied pre-money moves to $7.5M without changing anything else. This is why understanding the investor's assumptions matters more than accepting the offer at face value.
How to Choose the Right Valuation Method
The wrong first question is "what stage are we at?" Stage is a useful shorthand but a poor decision framework. Two Series A companies with the same round size can be in completely different positions: one with eighteen months of revenue history and measurable unit economics, one that closed a round on a product demo and an ARR projection. The right method for each is not the same.
The better question is three questions. What data do you have? Who is your audience? And what is the purpose of the valuation?
Trigger 1: What data do you have?
Data availability is the most honest filter. If there is no revenue and no unit economics, DCF is an assumption exercise and comps rely on KPI proxies rather than financial metrics. The VC method is the only tool that does not require financial data, which is precisely why angels and pre-seed funds use it. As revenue appears and unit economics become measurable, comps strengthen significantly and DCF becomes progressively more meaningful. By the time a company has two or more years of revenue with visible retention and margin patterns, all three methods can be run in parallel and triangulated.
Trigger 2: Who is your audience?
The method should reflect how the audience on the other side of the table prices deals. An angel investor is running a VC method internally regardless of what you present. A Series A institutional fund is running comps and a growth-adjusted multiple framework. A strategic acquirer is running a DCF alongside a synergy model and looking at what your revenue base is worth to their existing business. A financial buyer is running a returns-based DCF with leverage assumptions built in.
Presenting a DCF to an angel is not wrong, but it is not how they think. Presenting only a VC method output to a strategic acquirer signals that the founder does not understand how the buyer is approaching the deal. Matching the method to the audience is not about telling them what they want to hear. It is about speaking the same analytical language.
Trigger 3: What is the purpose?
A valuation built for a fundraising round, a valuation built for an M&A conversation, and a valuation built for internal planning are three different outputs even if the underlying business is identical. Fundraising valuations emphasise growth potential and market positioning. M&A valuations emphasise revenue quality, retention, and what the business looks like inside an acquirer's portfolio. Internal planning valuations emphasise scenario ranges and decision sensitivity. The method mix shifts accordingly.
How the methods stack in practice
In most real engagements, the answer is not one method. It is a primary method anchored to the context, with one or two additional methods used as cross-checks to build a defensible range.
A pre-seed company raising from angels uses the VC method as the pricing anchor, with comps on KPI multiples as a sanity check. A Series A company uses comps as the primary method, with a simple DCF to test whether the implied valuation is consistent with the growth story. A late-stage company preparing for M&A uses DCF as the primary method, with comps to validate the multiple range and a VC method only if a financial buyer is involved and return logic matters to the deal structure.
The goal is never a single number. It is a range with explicit assumptions behind it, built from multiple perspectives, that holds up when the investor or acquirer runs their own analysis.
The goal is a defensible range, not a single number. Primary and supporting methods should be consistent with each other. Where they diverge, the gap itself is useful information about where the risk or upside is concentrated.
Why Investors Triangulate Across Methods
When a founder walks into a fundraising conversation with a valuation, the investor on the other side of the table is not accepting that number at face value. They are running their own analysis. In most cases, that means running at least two methods independently and seeing whether the results are consistent with what the founder is presenting.
This is not adversarial. It is how any rigorous financial analysis works. The reason investors triangulate is the same reason any practitioner does: no single valuation method is complete on its own. Comps tell you where the market is pricing similar businesses but say nothing about whether your specific business deserves a premium or discount to that range. DCF captures the internal logic of your growth story but depends entirely on assumptions that can be challenged. The VC method tells an investor whether the deal works for their fund but has no relationship to what the business is fundamentally worth. Each method illuminates a different dimension of value. None of them produces the full picture alone.
The practical consequence for founders is that a valuation built on one method is inherently fragile. If your number comes entirely from a comp set and the investor's comp set is different, the conversation immediately becomes a debate about peer selection rather than a discussion about your business. If your number comes entirely from a DCF and the investor challenges your discount rate or terminal growth assumption, the entire valuation shifts. A range built from multiple methods that converge on a consistent answer is significantly harder to destabilise because attacking one method does not collapse the others.
Triangulation also tells you something useful when the methods do not converge. If your comps suggest a range of $20M to $30M but your DCF produces $8M, that gap is not a problem to hide. It is information. It usually means the growth assumptions in the DCF are too conservative relative to what the market is pricing in for comparable businesses, or that the comp set includes peers at a later stage of development than your current position warrants. Understanding why the methods diverge strengthens your ability to defend the range you ultimately present.
This is the underlying logic behind building a valuation from strategy first rather than from a target number backwards. When the method choice, the assumptions, and the resulting range all follow from a coherent view of how the business operates and where it is going, the valuation holds together under scrutiny regardless of which method an investor chooses to probe first.
Common Mistakes That Undermine Any Valuation
The method-specific mistakes covered in the sections above tend to be technical: wrong peer set, terminal value dominance, over-reliance on a return construct. The mistakes below cut across all three methods. They are less about the mechanics of valuation and more about the judgment and process behind it.
Building backwards from a target number
The most corrosive mistake in startup valuation is deciding what number you want and then selecting the method and assumptions that produce it. It is more common than most founders would admit, and investors recognise it immediately. A comp set that excludes all the lower-trading peers, a DCF with a discount rate two points below market, a terminal growth rate set at the high end of what is defensible: each one individually might be explained away, but together they signal a valuation built to reach a conclusion rather than to test one.
The damage is not just reputational. A valuation built backwards creates a fragile negotiating position because any challenge to a single assumption threatens the entire output. A valuation built forwards, from honest assumptions to a resulting range, is stable under pressure because the assumptions themselves are the argument.
Presenting a single number instead of a range
A precise valuation number sounds confident. It is usually a sign that the analysis is incomplete. Any honest valuation exercise, run across multiple methods with explicit assumptions, produces a range. The width of that range is informative: a narrow range signals high conviction and strong data, a wide range signals uncertainty that should be acknowledged and explained rather than hidden behind a single figure.
Presenting a single number in an investor conversation also gives away negotiating leverage. A range with a clear floor and a justified ceiling gives both parties something to work with. A single number invites a counter-number, and the conversation becomes a tug of war rather than a discussion about assumptions and value drivers.
Confusing price with value
Valuation and price are not the same thing. Value is what the analytical framework produces. Price is what two parties agree on given their respective positions, alternatives, and negotiating dynamics. A company can be worth $15M by every reasonable method and close a round at $10M because the founder needed capital quickly, or at $22M because a strategic investor was willing to pay a premium for access to the technology.
The confusion becomes a problem when founders treat the price from their last round as the validated value of their business, then use it as the anchor for the next round without rebuilding the analysis. Market conditions change, comparables shift, and a price that was fair eighteen months ago may be significantly above or below where the market sits today. Valuation is not a permanent fact. It is a point-in-time output that needs to be rebuilt whenever the context changes.
Not being able to defend the assumptions in a live conversation
A valuation memo or model that cannot be explained by the person presenting it is worse than no valuation at all. Investors test assumptions in real time. They will ask why a specific discount rate was chosen, why a particular company was included in the comp set, what happens to the DCF output if churn is two points higher than projected. If the answer is "our advisor built it" or a long pause while slides are scrolled through, the credibility of the entire analysis collapses.
The goal is not to memorise the model. It is to understand the logic well enough to engage with challenges directly and confidently. That requires being involved in the process of building the analysis, not just receiving the output.
If any of these apply to your current valuation, the right move is to rebuild before the next investor conversation, not during it.
Why Founders Work With Finro on Startup Valuation
Most valuation providers deliver a number. The number is usually defensible on paper. What it often lacks is the logic underneath it: the explicit assumptions, the rationale behind the comp selection, the scenario thinking that tells a founder what needs to be true for the upside to materialise and what the downside looks like if it does not.
That gap is where fundraising and M&A conversations break down. Not because the number was wrong, but because the founder could not explain how it was reached or engage confidently when an investor challenged a specific assumption.
Finro's approach starts with strategy and positioning before a single comp is pulled or a projection is modelled. The goal is to understand how the business operates, what drives value, who the likely investor or acquirer is, and what level of scrutiny the output will face. The valuation follows from that context. It is not the starting point.
What this looks like in practice
Every engagement begins with aligning on purpose: is this for a fundraising round, an M&A conversation, a board discussion, or internal planning? Each context demands a different emphasis, a different primary method, and a different level of scenario detail. Getting this right at the start is what makes the output usable rather than generic.
Comp selection follows Finro's niche decomposition process. Rather than matching on sector category, the analysis breaks the company's business model into the specific niches that together approximate how it operates and generates value. Each niche is researched across private companies, public companies, and M&A transactions, with weighting applied based on the context: higher weight to M&A deals in an acquisition scenario, higher weight to early-stage peers for pre-revenue companies, higher weight to the dominant niche where revenue is most concentrated.
Scenario clarity is built in from the start rather than added as a footnote. Every engagement produces a base case, a downside, and an upside, with explicit drivers behind each outcome. The goal is not a range that sounds plausible. It is a range the founder can walk an investor through assumption by assumption and defend at every step.
Speed and quality are not traded off. Finro's process is structured enough to move quickly without cutting corners on the analysis that matters. Most engagements run three to five weeks depending on complexity and data readiness.
Every conversation is directly with Lior. Not a junior analyst, not an intake form first. Founders working with Finro engage with someone who has supported over 200 technology companies across AI, fintech, cybersecurity, SaaS, and deep tech, across more than $1.4 billion in transactions, across fifteen countries.
Startup valuation is not a formula you apply once and present with confidence. It is a judgment call made within a framework, shaped by your data, your audience, and the context of the decision at hand. Getting that judgment right, and being able to defend it when it is challenged, is what separates a valuation that moves a conversation forward from one that stalls it.
- 1 Method choice is a strategic decision, not a technical one. The right method depends on what data you have, who your audience is, and what the valuation is for. Stage is a useful shorthand but a poor decision framework on its own.
- 2 Comps apply at almost every stage — but what they measure changes. Pre-revenue comps rely on KPI proxies like ARR, GMV, and sector multiples. Post-revenue comps anchor to EV/Revenue and EV/EBITDA. The method is consistent. The inputs shift significantly as the business matures.
- 3 DCF is most powerful when built from the same data foundation as your comp set. Beta, unit economics, and retention data collected during comp research feed directly into a credible DCF. Building both from the same foundation keeps the methods consistent and the resulting range defensible.
- 4 The VC method tells you how an investor priced the deal — not what your company is worth. Understanding how an angel or pre-seed fund sizes a deal internally puts founders in a significantly stronger negotiating position. Run the method yourself before the conversation, not after the offer arrives.
- 5 A range from multiple methods is significantly harder to destabilise than a single number. Investors triangulate independently. A valuation built from multiple methods that converge on a consistent range holds up when one method is challenged because the others remain intact.
- 6 Investors will run their own analysis regardless. The goal is not to present a number they have not seen before. It is to be consistent with what they find when they run their own model, so the conversation moves forward on strategy rather than stalling on a number no one agrees on.
